SELENBP1 and pancreatic ductal adenocarcinoma: Since MTO not only effectively disrupts DNA synthesis and DNA repair, but also induces immunogenic cell death, the multiple effects of MTO combined with the targeting capacity of SPIONs might be a future approach for the therapy of pancreatic ductal adenocarcinoma [27,28].